Skip to main content
. 2020 Oct 29;12(10):e11244. doi: 10.7759/cureus.11244

Table 2. Demographic and clinical variables and their association with Chlamydia trachomatis in men.

dL: Deciliter; ED: Emergency department; EMS: Emergency medical services; HPF: High-power field; mg: milligram; NA: Not applicable; OR: Odds ratio; PCP: Primary care physician; SD: Standard deviation; STD: Sexually transmitted disease; STI: Sexually transmitted infection; UTI: Urinary tract infection; vs: versus; WBC: White blood cell; y: year.

Adjusting for age, race, and emergency severity index score. ORs for continuous variables are stated as per unit change in regressor.

  + C trachomatis − C trachomatis P Value Adjusted OR (95% CI) Adjusted P Value
Age, mean (SD), y 25.2 (6.4) (n = 457) 31.8 (11.2) (n = 2,673) < .001 .91 (.90-.93) < .001
Black race (vs not Black) 91.0% (414/455) 86.4% (2,293/2,655) .006 1.40 (.99-1.99) .06
Married/life partner (vs not married) 2.9% (13/454) 9.6% (255/2,660) < .001 .67 (.37-1.22) .19
Emergency severity index score, mean (SD), level 1-5 3.8 (.5) (n = 435) 3.6 (.6) (n = 2,524) < .001 1.13 (.95-1.35) .17
Having a (PCP) (vs none) 16.9% (77/457) 18.8% (503/2,673) .33 .84 (.63-1.11) .21
Arrived to ED by EMS/police (vs other) 2.0% (9/455) 3.8% (100/2,647) .05 .56 (.26-1.19) .13
ED triage pain scale, mean (SD) (0-10) 2.6 (3.6) (n = 24) 3.4 (3.8) (n = 234) .31 1.02 (.77-1.35) .89
Mentioned “STD,” “STI,” “sexually transmitted,” “penis,” or “discharge” at ED point of contact (vs not) 59.1% (270/457) 45.2% (1,208/2,673) < .001 1.44 (1.15-1.81) .002
Mentioned “UTI,” “bladder infection” or “pain,” “urinary tract infection,” “cystitis,” “dysuria,” “frequency” or “frequent urination,” or “urgency” at ED point of contact (vs not) 3.9% (18/457) 4.8% (127/2,673) .55 .96 (.54-1.70) .88
Mentioned “abdominal pain,” “abdominal discomfort,” or “abdominal cramping” at ED point of contact (vs not) 5.0% (23/457) 5.9% (158/2,673) .52 1.02 (.63-1.65) .94
Diagnosed in the ED with a urinary tract infection (vs not) 7.9% (36/457) 4.3% (114/2,673) .002 2.68 (1.75-4.10) < .001
Treated with metronidazole in the ED or given it as an outpatient prescription (vs not) 35.4% (162/457) 30.2% (808/2,673) .03 1.12 (.90-1.41) .31
Treated for gonorrhea and chlamydia (vs not) 81.2% (371/457) 58.8% (1,573/2,673) < .001 2.67 (2.05-3.47) < .001
Infected with N gonorrhoeae (vs not) 25.1% (114/455) 11.4% (304/2,664) < .001 1.93 (1.49-2.51) < .001
Infected with T vaginalis (vs not) 8.0% (9/112) 8.7% (59/677) > .99 1.09 (.47-2.55) .84
Urinalysis          
WBC count (cells/HPF), mean (SD) 42.1 (35.5) (n = 198) 29.9 (37.5) (n = 846) < .001 1.01 (.99-1.05) .33
WBC clumps present (vs not) 6.6% (13/197) 9.3% (78/837) .26 .65 (.33-1.25) .19
Mucus (0, 1+, 2+, 3+, or 4+), mean (SD) 1.1 (1.3) (n = 198) 1.2 (1.1) (n = 846) .19 1.00 (.88-1.12) .95
Leukocyte esterase (0, 1+, 2+, or 3+), mean (SD) 1.1 (1.0) (n = 246) 0.6 (1.0) (n = 1,593) < .001 1.56 (1.38-1.77) < .001
Bacteria (0, 1+, 2+, 3+, or 4+), mean (SD) 0.5 (.7) (n = 198) 0.6 (.9) (n = 845) .02 .91 (.74-1.13) .41
Nitrite positive (vs negative) 0.4% (1/250) 2.1% (33/1,606) .08 .43 (.06-3.28) .41
Blood (0, 1+, 2+, or 3+), mean (SD) 0.3 (.7) (n = 250) 0.3 (.7) (n = 1,587) .92 1.17 (.96-1.42) .11
Red blood cells (cells/HPF), mean (SD) 9.7 (21.8) (n = 198) 12.1 (24.7) (n = 843) .18 1.00 (.99-1.01) .63
Squamous epithelial cells (cells/HPF), mean (SD) 0.8 (3.3) (n = 57) 1.2 (2.5) (n = 220) .39 .98 (.87-1.11) .74
pH (5-9), mean (SD) 6.2 (.9) (n = 250) 6.0 (.9) (n = 1,607) .004 1.10 (.95-1.28) .20
Bilirubin (0, 1+, 2+, or 3+), mean (SD) 0.1 (.5) (n = 250) 0.04 (.3) (n = 1,602) .06 1.51 (1.08-2.11) .02
Urobilinogen (0, 2, 4, 8, or 12 mg/dL), mean (SD) 1.1 (1.7) (n = 250) 0.8 (1.6) (n = 1,606) .01 1.04 (.96-1.13) .34
Protein (0, .5+, 1+, 2+, 3+), mean (SD) .4 (.6) (n = 250) .3 (.6) (n = 1,606) .18 1.23 (.98-1.54) .07
Glucose present (vs not) .4% (1/250) 5.2% (83/1,604) < .001 .15 (.02-1.12) .06
Ketones (0, .5+, 1+, 2+, 3+), mean (SD) .1 (.4) (n = 250) .1 (.4) (n = 1,604) .79 .97 (.66-1.41) .86